2m 2m 2m 2m 2m 2m 2m
NEURONETICS (STIM)
NASDAQ
$1.40-$0.17 (-10.58%)
Price as of Jun 03, 2026 7:44 PM EDT- $107.2MMarket Cap
- -59.59%1-Year Change
- Medical DevicesIndustry
NEURONETICS (STIM)
$1.40-$0.17 (-10.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 62.2M -16.97% | 74.9M +4.96% | 71.3M +9.42% | 65.2M +17.89% | |
Cost of Revenue | 16.5M -20.58% | 20.7M +5.53% | 19.6M +26.87% | 15.5M +32.87% | |
Gross Profit | 72.3M +33.51% | 54.2M +4.75% | 51.7M +3.99% | 49.7M +13.89% | |
Sales and Marketing Expense | 47.5M +4.00% | 45.6M -3.57% | 47.3M -5.33% | 50.0M +32.42% | |
Research and Development Expense | -6.6M -48.45% | -12.8M +34.22% | -9.5M +1.92% | -9.3M +17.83% | |
Depreciation and Amortization Expense | 3.5M +67.15% | 2.1M +3.34% | 2.0M +21.72% | 1.6M +55.47% | |
Total Operating Expenses | 103.7M +16.93% | 88.7M +7.86% | 82.3M -3.04% | 84.8M +19.11% | |
Operating Profit | -31.4M -9.05% | -34.6M +13.12% | -30.6M -12.98% | -35.1M +27.38% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -7.3M +34.33% | -5.4M +27.59% | -4.3M +5.77% | |
Interest Income and Expense and Net | 0 +100.00% | -7.3M +34.33% | -5.4M +27.59% | -4.3M +5.77% | |
Total Nonoperating Income and Expense | 716,000 -71.91% | 2.5M -55.97% | 5.8M +162.78% | 2.2M +464.87% | |
Income before Taxes | -31.4M -9.05% | -34.6M +13.12% | -30.6M -12.98% | -35.1M +27.38% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -39.0M -10.78% | -43.7M +44.78% | -30.2M -18.76% | -37.2M +19.13% | |
Net Income from Continuing Operations Applicable to Common | -39.0M -10.78% | -43.7M +44.78% | -30.2M -18.76% | -37.2M +19.13% | |
Basic EPS and Net Income | -0.59 -57.25% | -1.38 +31.43% | -1.05 -23.91% | -1.38 +13.11% | |
Diluted EPS and Net Income | -0.59 -57.25% | -1.38 +31.43% | -1.05 -23.91% | -1.38 +13.11% | |
Basic Weighted Average Shares | 66.0M +107.82% | 31.7M +10.73% | 28.7M +6.54% | 26.9M +5.58% | |
Diluted Weighted Average Shares | 66.0M +107.82% | 31.7M +10.73% | 28.7M +6.54% | 26.9M +5.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 28.1M +52.41% | 18.5M -69.07% | 59.7M -15.16% | 70.3M -25.28% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 28.1M +52.41% | 18.5M -69.07% | 59.7M -15.16% | 70.3M -25.28% | |
Total Current Assets | 61.6M +5.90% | 58.1M -38.03% | 93.8M -5.04% | 98.8M -14.36% | |
Accumulated Depreciation | 4.1M +24.91% | 3.2M +14.95% | 2.8M -7.69% | 3.1M +20.50% | |
Property and Plant and Equipment and Net | 4.5M -28.45% | 6.2M +210.70% | 2.0M +0.90% | 2.0M +63.20% | |
Total Long-Term Assets | 2.0M +3.07% | 1.9M -56.59% | 4.4M +21.54% | 3.6M +64.34% | |
Total Assets | 141.6M +0.46% | 140.9M +21.65% | 115.8M -0.90% | 116.9M -17.23% | |
Income Taxes Payable | 611,000 -1.29% | 619,000 -24.33% | 818,000 +24.13% | 659,000 -0.75% | |
Total Short-Term Debt | 70.0M +16.67% | 60.0M +357.14% | 13.1M 0.00% | 13.1M -62.50% | |
Total Current Liabilities | 30.5M -2.38% | 31.3M +57.81% | 19.8M -40.32% | 33.2M +111.42% | |
Total Long-Term Debt | 65.8M +19.32% | 55.2M -6.97% | 59.3M +159.68% | 22.8M -35.39% | |
Total Long-Term Liabilities | 84.8M +8.93% | 77.8M +25.89% | 61.8M +132.22% | 26.6M -34.01% | |
Total Liabilities | 115.3M +5.69% | 109.1M +33.64% | 81.6M +36.47% | 59.8M +6.74% | |
Retained Earnings | -458.8M +9.29% | -419.8M +11.62% | -376.1M +8.73% | -345.9M +12.04% | |
Total Stockholders Equity | 22.4M -19.23% | 27.7M -18.96% | 34.2M -40.08% | 57.1M -33.01% | |
Total Shares Outstanding | 69.0M +23.91% | 55.7M +91.39% | 29.1M +6.69% | 27.3M +3.31% | |
Cash Flow | |||||
Cash from Operating Activities | -20.4M -34.27% | -31.0M -3.25% | -32.0M +4.23% | -30.7M +9.85% | |
Capital Expenditures | 801,000 -45.36% | 1.5M -38.12% | 2.4M -27.53% | 3.3M +38.93% | |
Cash from Investing Activities | -801,000 -66.80% | -2.4M +82.53% | -1.3M -119.64% | 6.7M +168.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 35.9M +626.59% | -6.8M -130.00% | 22.7M +10,864.73% | 207,000 -99.75% | |
Financials Ratio | |||||
Gross Margin | 73.52% +1.66% | 72.32% -0.20% | 72.47% -4.97% | 76.26% -3.39% | |
Operating Margin | -50.56% +9.54% | -46.15% +7.77% | -42.82% -20.47% | -53.85% +8.05% | |
Return on Assets | -27.61% -18.90% | -34.05% +31.24% | -25.94% -9.89% | -28.79% +1.48% | |
Return on Equity | -155.73% +10.27% | -141.23% +113.44% | -66.17% +26.64% | -52.25% -7.31% | |
Revenue Growth | -16.97% -441.87% | 4.96% -47.30% | 9.42% -47.34% | 17.89% +45.16% | |
Current Ratio | 2.02 +8.48% | 1.86 -60.73% | 4.73 +59.13% | 2.98 -59.49% | |
Cash Ratio | 0.92 +56.13% | 0.59 -80.40% | 3.01 +42.17% | 2.12 -64.66% | |
Debt-to-Equity Ratio | 6.07 +46.02% | 4.16 +96.25% | 2.12 +236.11% | 0.63 -23.70% | |
Debt-to-Assets Ratio | 0.96 +17.40% | 0.82 +30.73% | 0.63 +103.22% | 0.31 -38.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow